[HTML][HTML] Diagnostic biomarkers of amyloid and tau pathology in Alzheimer's disease: an overview of tests for clinical practice in the United States and Europe
Amyloid and tau biomarkers for Alzheimer's disease are widely recognized diagnostic tools
for the identification of Alzheimer's disease pathology antemortem and are recommended by …
for the identification of Alzheimer's disease pathology antemortem and are recommended by …
[HTML][HTML] Diagnostic biomarkers in Alzheimer's disease
E Andersen, B Casteigne, WD Chapman… - Biomarkers in …, 2021 - Elsevier
In this review article we examine the various types of diagnostic biomarkers which are used
in the early detection of Alzheimer's disease. This review summerizes the A/T/N …
in the early detection of Alzheimer's disease. This review summerizes the A/T/N …
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers
PET, CSF and plasma biomarkers of tau pathology may be differentially associated with
Alzheimer's disease (AD)‐related demographic, cognitive, genetic and neuroimaging …
Alzheimer's disease (AD)‐related demographic, cognitive, genetic and neuroimaging …
Associations of fully automated CSF and novel plasma biomarkers with Alzheimer disease neuropathology at autopsy
Objective To study CSF biomarkers of Alzheimer disease (AD) analyzed by fully automated
Elecsys immunoassays compared to neuropathologic gold standards and to compare their …
Elecsys immunoassays compared to neuropathologic gold standards and to compare their …
Evaluation of plasma biomarkers for a/T/N classification of Alzheimer disease among adults of Caribbean Hispanic ethnicity
Importance Cerebrospinal fluid (CSF) and plasma biomarkers can detect biological
evidence of Alzheimer disease (AD), but their use in low-resource environments and among …
evidence of Alzheimer disease (AD), but their use in low-resource environments and among …
Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction
We investigated whether the impact of tau-pathology on memory performance and on
hippocampal/medial temporal memory function in non-demented individuals depends on …
hippocampal/medial temporal memory function in non-demented individuals depends on …
Direct to Consumer Biomarker Testing for Alzheimer Disease—Are We Ready for the Insurance Consequences?
QuestDiagnosticsintroducedthefirst-to-marketdirectto-consumer (DTC) biomarker test for
Alzheimer disease (AD) on July 31, 2023. The test provides consumers a blood draw at the …
Alzheimer disease (AD) on July 31, 2023. The test provides consumers a blood draw at the …
Neuroimaging phenotypes of CSF1R‐related leukoencephalopathy: Systematic review, meta‐analysis, and imaging recommendations
GC Mickeviciute, M Valiuskyte, M Plattén… - Journal of Internal …, 2022 - Wiley Online Library
Colony‐stimulating factor 1 receptor (CSF1R)‐related leukoencephalopathy is a rare but
fatal microgliopathy. The diagnosis is often delayed due to multifaceted symptoms that can …
fatal microgliopathy. The diagnosis is often delayed due to multifaceted symptoms that can …
Development of SERS Active Nanoprobe for Selective Adsorption and Detection of Alzheimer's Disease Biomarkers Based on Molecular Docking
Purpose Development of SERS-based Raman nanoprobes can detect the misfolding of
Amyloid beta (Aβ) 42 peptides, making them a viable diagnostic technique for Alzheimer's …
Amyloid beta (Aβ) 42 peptides, making them a viable diagnostic technique for Alzheimer's …
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease
Cognitive impairment is a prevalent non-motor symptom of Parkinson's disease (PD), which
can result in significant disability and distress for patients and caregivers. There is a marked …
can result in significant disability and distress for patients and caregivers. There is a marked …